ARTV Artiva Biotherapeutics, Inc.
Healthcare$7.67-2.54%ClosedMarket Cap: $189.6M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$37.50
Target (Median)
$37.50
Target Range
$35.00 - $40.00
Upside from current price: 388.9%
Rating Distribution
1 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-12 | Needham | maintain | Buy | Buy |
| 2026-05-11 | Wedbush | maintain | Outperform | Outperform |
| 2026-05-11 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2026-05-08 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-11 | Needham | maintain | Buy | Buy |
| 2025-11-12 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-17 | Needham | maintain | Buy | Buy |
| 2025-10-17 | Wedbush | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.91 | $0.00 | 4 |
| Sun Dec 31 | $-3.05 | $1.7M | 5 |
| Mon Dec 31 | $-2.58 | $41.1M | 1 |
| Tue Dec 31 | $-1.11 | $207.2M | 1 |